Cases & Deals

ADOCIA completes €31.9 million private placement of new shares

Clients ADOCIA

Jones Day advised ADOCIA, a clinical-stage biotechnology company that specializes in the development of innovative formulations of already-approved therapeutic proteins, in connection with its €31.9 million (US$34.4 million) private placement of new shares to U.S. and European investors.

We use cookies to deliver our online services. Details of the cookies and other tracking technologies we use and instructions on how to disable them are set out in our Cookies Policy. By using this website you consent to our use of cookies.